Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Nov 17;18(3):396–405. doi: 10.1016/j.bbmt.2011.11.013

Figure 3. CDDO-Me administration results in a significant increase of CFU-GM and BFU-e in the BM and periphery.

Figure 3

Mice were treated with vehicle control (VC), CDDO-me or G-CSF as before. CFU-GM and BFU-e colony assays were performed on bone marrow, spleens, and peripheral blood of treated animals. The data is representative of three independent experiments with three mice per group per experiment. Statistical differences were determined by one-way ANOVA with Tukey’s post-test and a p-value<0.05 was considered significant.